Avanza Fonder Ab Bridge Bio Pharma, Inc. Transaction History
Avanza Fonder Ab
- $3.37 Trillion
- Q4 2024
A detailed history of Avanza Fonder Ab transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Avanza Fonder Ab holds 6,581 shares of BBIO stock, worth $224,477. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,581Holding current value
$224,477% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding BBIO
# of Institutions
294Shares Held
170MCall Options Held
10.3MPut Options Held
2.37M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$862 Million35.94% of portfolio
-
Viking Global Investors LP25.1MShares$857 Million2.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$484 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$425 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$207 Million63.58% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5.06B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...